Iguratimod (25 mg) Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Iguratimod (25 mg) Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: DMARD (Methotrexate Alternative)
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Iguratimod (25 mg) Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Iguratimod (25 mg) Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Iguratimod (25 mg) Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Iguratimod (25 mg) formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Rheumatoid arthritis (DMARD-naïve or DMARD-resistant)
- Combination with Methotrexate
- Methotrexate-intolerant patients
- Ankylosing spondylitis
Mechanism of Action
Iguratimod inhibits NF-κB nuclear translocation reducing pro-inflammatory cytokine transcription (TNF-α, IL-6, IL-1β, IL-8). Also reduces immunoglobulin synthesis by B-cells. Slower onset than corticosteroids but disease-modifying.
Dosage & Administration
- Adults: 25 mg once daily for 4 weeks, then increase to 25 mg twice daily.
Side Effects
- GI upset, abnormal LFTs (monitor every 4 weeks initially), rash, infection risk.
Contraindications
- Severe hepatic impairment, pregnancy, lactation, severe infections, hypersensitivity, on warfarin (interaction).
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Iguratimod (25 mg) Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Alu Alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Iguratimod (25 mg) Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Iguratimod (25 mg) Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Iguratimod (25 mg) Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Iguratimod (25 mg) Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Iguratimod (25 mg) Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Iguratimod (25 mg) Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Iguratimod (25 mg) Tablet?
Available pack sizes include: 10 x 10 (Alu Alu).
What is the MRP / trade price for Iguratimod (25 mg) Tablet?
MRPs range from ₹3300 to ₹3300 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Iguratimod (25 mg) Tablet?